ICON Management
Management Kriterienprüfungen 4/4
ICON CEO ist Steve Cutler , ernannt in Mar 2017, hat eine Amtszeit von 7.67 Jahren. Die jährliche Gesamtvergütung beträgt $7.24M , bestehend aus 16.4% Gehalt und 83.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.045% der Aktien des Unternehmens, im Wert von $7.95M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 8.3 Jahre bzw. 7.6 Jahre.
Wichtige Informationen
Steve Cutler
Geschäftsführender
US$7.2m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 16.4% |
| Amtszeit als Geschäftsführer | 7.7yrs |
| Eigentum des Geschäftsführers | 0.04% |
| Durchschnittliche Amtszeit des Managements | 8.3yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 7.6yrs |
Jüngste Management Updates
Recent updates
With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For
Nov 02
Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors
Sep 25Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Sep 09We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt
Aug 25An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued
Aug 10ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
Jul 13Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)
Jun 14Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching
May 30ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet
May 14ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 28What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?
Apr 21ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price
Apr 05ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump
Mar 05With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Feb 07ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
Feb 01These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Jan 23Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jan 08What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E
Dec 24A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Dec 09With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Nov 08Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Oct 09Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Sep 23Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Sep 05Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?
Aug 03Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jun 30Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Jun 12Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
May 23Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Mar 29Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Mar 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?
Feb 21Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Dec 28These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Dec 10Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?
Nov 22Icon selected by BARDA to conduct anthrax vaccine clinical trial
Oct 06Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?
Sep 15ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly
Aug 26Baron Funds - ICON Plc: Positioned For An Extended Period Of Revenue And Earnings Growth
Aug 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?
Aug 01Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$748m |
| Jun 30 2024 | n/a | n/a | US$714m |
| Mar 31 2024 | n/a | n/a | US$683m |
| Dec 31 2023 | US$7m | US$1m | US$612m |
| Sep 30 2023 | n/a | n/a | US$513m |
| Jun 30 2023 | n/a | n/a | US$510m |
| Mar 31 2023 | n/a | n/a | US$510m |
| Dec 31 2022 | US$10m | US$1m | US$505m |
| Sep 30 2022 | n/a | n/a | US$464m |
| Jun 30 2022 | n/a | n/a | US$210m |
| Mar 31 2022 | n/a | n/a | US$168m |
| Dec 31 2021 | US$10m | US$1m | US$153m |
| Sep 30 2021 | n/a | n/a | US$178m |
| Jun 30 2021 | n/a | n/a | US$364m |
| Mar 31 2021 | n/a | n/a | US$338m |
| Dec 31 2020 | US$8m | US$1m | US$328m |
| Sep 30 2020 | n/a | n/a | US$322m |
| Jun 30 2020 | n/a | n/a | US$324m |
| Mar 31 2020 | n/a | n/a | US$368m |
| Dec 31 2019 | US$8m | US$1m | US$369m |
| Sep 30 2019 | n/a | n/a | US$362m |
| Jun 30 2019 | n/a | n/a | US$353m |
| Mar 31 2019 | n/a | n/a | US$333m |
| Dec 31 2018 | US$8m | US$1m | US$323m |
| Sep 30 2018 | n/a | n/a | US$306m |
| Jun 30 2018 | n/a | n/a | US$295m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$7m | US$1m | US$281m |
Vergütung im Vergleich zum Markt: SteveDie Gesamtvergütung ($USD7.24M) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD12.66M).
Entschädigung vs. Einkommen: SteveDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Steve Cutler (64 yo)
7.7yrs
Amtszeit
US$7,244,000
Vergütung
Dr. Steven A. Cutler, also known as Steve, Ph D., MBA, serves as Chairman of Association of Clinical Research Organizations since January 01, 2021. He has been the Chief Executive Officer of ICON Public Li...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 7.7yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | no data | US$290.00k | 0.54% $ 96.4m | |
| Chief Financial Officer | less than a year | keine Daten | keine Daten | |
| Senior Vice President of Corporate & Commercial Finance | no data | keine Daten | keine Daten | |
| Chief Information Officer | no data | keine Daten | keine Daten | |
| Chief Administrative Officer | 15yrs | keine Daten | 0.0097% $ 1.7m | |
| Director of Corporate Communications | no data | keine Daten | keine Daten | |
| Vice President of Marketing | no data | keine Daten | keine Daten | |
| Chief Human Resources Officer | 8.3yrs | keine Daten | keine Daten | |
| President of Corporate Investments & Partnerships | 2yrs | keine Daten | keine Daten | |
| Senior Vice President of Global Clinical Pharmacology | 15.6yrs | keine Daten | keine Daten | |
| Senior Vice President of Drug Development Services - CNS | 17.8yrs | keine Daten | keine Daten |
8.3yrs
Durchschnittliche Betriebszugehörigkeit
53.5yo
Durchschnittliches Alter
Erfahrenes Management: ICLRDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (8.3 ).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 9yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | 14.8yrs | US$290.00k | 0.54% $ 96.4m | |
| Independent Director | 3.3yrs | US$303.00k | 0.0054% $ 949.9k | |
| Independent Non-Executive Director | 7.1yrs | US$323.00k | 0.0026% $ 454.6k | |
| Independent Non-Executive Chairman of the Board | 13.1yrs | US$656.00k | 0.023% $ 4.1m | |
| Lead Independent Director | 8.1yrs | US$359.00k | 0.0026% $ 454.6k | |
| Non-Executive Director | less than a year | keine Daten | keine Daten | |
| Independent Non-Executive Director | 5.3yrs | US$315.00k | 0.0023% $ 413.9k |
7.6yrs
Durchschnittliche Betriebszugehörigkeit
64.5yo
Durchschnittliches Alter
Erfahrener Vorstand: ICLRDie Vorstandsmitglieder gelten als erfahren (7.6 Jahre durchschnittliche Amtszeit).